NM_138554.5:c.260+1757C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_138554.5(TLR4):c.260+1757C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.178 in 150,886 control chromosomes in the GnomAD database, including 2,659 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.18   (  2659   hom.,  cov: 30) 
Consequence
 TLR4
NM_138554.5 intron
NM_138554.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.533  
Publications
61 publications found 
Genes affected
 TLR4  (HGNC:11850):  (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.235  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TLR4 | NM_138554.5  | c.260+1757C>T | intron_variant | Intron 2 of 2 | ENST00000355622.8 | NP_612564.1 | ||
| TLR4 | NM_003266.4  | c.140+1757C>T | intron_variant | Intron 3 of 3 | NP_003257.1 | |||
| TLR4 | NM_138557.3  | c.-340-1903C>T | intron_variant | Intron 1 of 1 | NP_612567.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TLR4 | ENST00000355622.8  | c.260+1757C>T | intron_variant | Intron 2 of 2 | 1 | NM_138554.5 | ENSP00000363089.5 | |||
| ENSG00000285082 | ENST00000697666.1  | c.140+1757C>T | intron_variant | Intron 3 of 4 | ENSP00000513391.1 | 
Frequencies
GnomAD3 genomes   AF:  0.178  AC: 26880AN: 150776Hom.:  2660  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
26880
AN: 
150776
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.178  AC: 26893AN: 150886Hom.:  2659  Cov.: 30 AF XY:  0.183  AC XY: 13485AN XY: 73652 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
26893
AN: 
150886
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
13485
AN XY: 
73652
show subpopulations 
African (AFR) 
 AF: 
AC: 
9789
AN: 
40976
American (AMR) 
 AF: 
AC: 
2013
AN: 
15168
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
532
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
1132
AN: 
5126
South Asian (SAS) 
 AF: 
AC: 
602
AN: 
4806
European-Finnish (FIN) 
 AF: 
AC: 
2881
AN: 
10306
Middle Eastern (MID) 
 AF: 
AC: 
45
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
9456
AN: 
67750
Other (OTH) 
 AF: 
AC: 
330
AN: 
2094
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.496 
Heterozygous variant carriers
 0 
 1053 
 2106 
 3159 
 4212 
 5265 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 276 
 552 
 828 
 1104 
 1380 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
538
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.